TransMedics Group Inc
$ 72.91
-0.92%
12 Jun - close price
- Market Cap 2,519,836,000 USD
- Current Price $ 72.91
- High / Low $ 75.00 / 71.33
- Stock P/E 16.68
- Book Value 13.81
- EPS 4.37
- Next Earning Report 2026-07-29
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.05 %
- ROE 0.45 %
- 52 Week High 156.00
- 52 Week Low 60.10
About
TransMedics Group, Inc., a commercial-stage medical technology company, is dedicated to transforming organ transplant therapy for patients with end-stage organ failure in the United States and internationally. The company is headquartered in Andover, Massachusetts.
Analyst Target Price
$116.78
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-05 | 2026-02-24 | 2025-10-29 | 2025-07-30 | 2025-05-08 | 2025-02-27 | 2024-10-28 | 2024-07-31 | 2024-04-30 | 2024-02-26 | 2023-11-06 | 2023-08-03 |
| Reported EPS | 0.3 | 0.051 | 0.66 | 0.92 | 0.7 | 0.19 | 0.12 | 0.35 | 0.35 | 0.12 | 0.07 | -0.03 |
| Estimated EPS | 0.61 | 0.3904 | 0.36 | 0.43 | 0.24 | 0.22 | 0.32 | 0.2 | 0.01 | -0.03 | -0.13 | -0.13 |
| Surprise | -0.31 | -0.3394 | 0.3 | 0.49 | 0.46 | -0.03 | -0.2 | 0.15 | 0.34 | 0.15 | 0.2 | 0.1 |
| Surprise Percentage | -50.8197% | -86.9365% | 83.3333% | 113.9535% | 191.6667% | -13.6364% | -62.5% | 75% | 3400% | 500% | 153.8462% | 76.9231% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-07-29 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 0.53 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: TMDX
2026-06-12 13:09:18
Johnson Fistel, PLLP is investigating TransMedics Group, Inc. (TMDX) on behalf of investors who suffered losses following recent financial disclosures. The investigation focuses on whether TransMedics complied with federal securities laws after reporting margin pressure, increased operating costs, and significant investments in growth and clinical programs. These disclosures led to a sharp decline in the company's stock price, prompting the law firm to examine potential recovery options for investors.
2026-06-12 11:10:14
Johnson Fistel, PLLP is investigating TransMedics Group, Inc. (NASDAQ: TMDX) on behalf of investors who may have suffered losses. This investigation follows recent financial disclosures from TransMedics, which reported increased revenue but declining gross and operating margins in Q1 2026 due to investments in growth and higher supply chain costs. The firm is examining whether TransMedics complied with federal securities laws, prompted by a sharp decline in the company's stock price after these disclosures.
2026-06-09 20:40:36
TransMedics Group (TMDX) surged 5.8% on Tuesday, closing at $75.29, amidst a broad sector-wide rally that lifted medical device stocks. The move was attributed to a coordinated sector rotation into medical device names by institutional investors, rather than company-specific news. Investors are advised to monitor whether this sector strength is sustainable or merely a short-term technical bounce.
2026-06-07 00:40:53
This article compiles various trade ideas and analyses for TransMedics Group, Inc. (TMDX) from different traders. It covers topics like recent earnings, stock performance, technical analysis indicators, and future expansion plans such as achieving full U.S. continent availability and strategic aircraft acquisition. The general sentiment among the traders leans bullish, with several recommending a "buy" position.
2026-06-06 22:40:53
This article displays the price to book ratio for TransMedics Group, Inc. (XETR:8T8) on TradingView. It provides market and financial data for the company, accessible through various features and tools on the TradingView platform. The content primarily focuses on presenting the financial metric within its user interface.
2026-06-06 15:39:23
This article compiles various trading ideas and analyses for TransMedics Group, Inc. (TMDX) from different traders on TradingView. The perspectives range from bullish long-term outlooks based on strong fundamentals and technical indicators, to short-term trade setups and risk assessments. Several analyses highlight TMDX's growth, financial health, and potential for significant price increases, while also cautioning about volatility and the importance of personal research.
